Skip to Content Facebook Feature Image

Japanese officials inspect 2 factories making health supplements linked to 5 deaths

News

Japanese officials inspect 2 factories making health supplements linked to 5 deaths
News

News

Japanese officials inspect 2 factories making health supplements linked to 5 deaths

2024-03-31 11:51 Last Updated At:12:00

TOKYO (AP) — Japanese government health officials on Sunday inspected a factory producing health supplements linked to at least five deaths and the hospitalization of more than 100 others, one day after the authorities investigated another plant that manufactured the product.

A team of 17 health officials from the central and prefectural governments raided a plant operated by the Kobayashi Pharmaceutical Co.'s subsidiary in Kinokawa, in the western Japanese prefecture of Wakayama, under the food sanitation act. NHK public television showed the officials walk into the factory.

More Images
Akihiro Kobayashi, president of Kobayashi Pharmaceutical Co., arrives at a news conference in Osaka, western Japan, Friday, March 29, 2024. In the week since a line of Japanese health supplements began being recalled, several people have died and more than 100 people were hospitalized as of Friday. The Osaka-based pharmaceutical company came under fire for not going public quickly with problems known internally as early as January. The first public announcement came March 22. (Yohei Fukuyama/Kyodo News via AP)

TOKYO (AP) — Japanese government health officials on Sunday inspected a factory producing health supplements linked to at least five deaths and the hospitalization of more than 100 others, one day after the authorities investigated another plant that manufactured the product.

An employee of Kobayashi Pharmaceutical Co. speaks to media members outside a plant operated by its subsidiary after Japan's health ministry officials walked into the plant to conduct an on-site inspection in Kinokawa, south of Osaka, western Japan, Sunday, March 31, 2024. Japanese government health officials on Sunday inspected the factory producing health supplements linked to several deaths and the hospitalization of more than 100 others, one day after the authorities investigated another plant that manufactured the product. (Yohei Fukai/Kyodo News via AP)

An employee of Kobayashi Pharmaceutical Co. speaks to media members outside a plant operated by its subsidiary after Japan's health ministry officials walked into the plant to conduct an on-site inspection in Kinokawa, south of Osaka, western Japan, Sunday, March 31, 2024. Japanese government health officials on Sunday inspected the factory producing health supplements linked to several deaths and the hospitalization of more than 100 others, one day after the authorities investigated another plant that manufactured the product. (Yohei Fukai/Kyodo News via AP)

Japan's health ministry officials walk into a plant operated by a subsidiary of Kobayashi Pharmaceutical Co. to conduct an on-site inspection in Kinokawa, south of Osaka, western Japan, Sunday, March 31, 2024. Japanese government health officials on Sunday inspected a factory producing health supplements linked to several deaths and the hospitalization of more than 100 others, one day after the authorities investigated another plant that manufactured the product. (Yohei Fukai/Kyodo News via AP)

Japan's health ministry officials walk into a plant operated by a subsidiary of Kobayashi Pharmaceutical Co. to conduct an on-site inspection in Kinokawa, south of Osaka, western Japan, Sunday, March 31, 2024. Japanese government health officials on Sunday inspected a factory producing health supplements linked to several deaths and the hospitalization of more than 100 others, one day after the authorities investigated another plant that manufactured the product. (Yohei Fukai/Kyodo News via AP)

Japan's health ministry officials walk towards a plant operated by a subsidiary of Kobayashi Pharmaceutical Co. to conduct an on-site inspection in Kinokawa, south of Osaka, western Japan, Sunday, March 31, 2024. Japanese government health officials on Sunday inspected a factory producing health supplements linked to several deaths and the hospitalization of more than 100 others, one day after the authorities investigated another plant that manufactured the product. (Yohei Fukai/Kyodo News via AP)

Japan's health ministry officials walk towards a plant operated by a subsidiary of Kobayashi Pharmaceutical Co. to conduct an on-site inspection in Kinokawa, south of Osaka, western Japan, Sunday, March 31, 2024. Japanese government health officials on Sunday inspected a factory producing health supplements linked to several deaths and the hospitalization of more than 100 others, one day after the authorities investigated another plant that manufactured the product. (Yohei Fukai/Kyodo News via AP)

A worker, left, for Kobayashi Pharmaceutical Co. stands as media members gather before Japan's health ministry officials arrive to conduct an on-site inspection at its plant in Osaka, western Japan, Saturday, March 30, 2024. Japanese government health officials raided a factory Saturday producing health supplements that they say have killed multiple people and hospitalized more than 100 others. (Yohei Fukai/Kyodo News via AP)

A worker, left, for Kobayashi Pharmaceutical Co. stands as media members gather before Japan's health ministry officials arrive to conduct an on-site inspection at its plant in Osaka, western Japan, Saturday, March 30, 2024. Japanese government health officials raided a factory Saturday producing health supplements that they say have killed multiple people and hospitalized more than 100 others. (Yohei Fukai/Kyodo News via AP)

Japan's health ministry officials walk towards the Osaka plant of Kobayashi Pharmaceutical Co. to conduct an on-site inspection in Osaka, western Japan, Saturday, March 30, 2024. Japanese government health officials raided a factory Saturday producing health supplements that they say have killed multiple people and hospitalized more than 100 others.

Japan's health ministry officials walk towards the Osaka plant of Kobayashi Pharmaceutical Co. to conduct an on-site inspection in Osaka, western Japan, Saturday, March 30, 2024. Japanese government health officials raided a factory Saturday producing health supplements that they say have killed multiple people and hospitalized more than 100 others.

The Wakayama plant took over the production of the supplements after Kobayashi Pharmaceutical closed another plant in nearby Osaka, which authorities searched on Saturday, NHK said.

Kobayashi Pharmaceutical spokesperson Yuko Tomiyama told reporters that the company is fully cooperating in the investigation.

The company says little is known about the exact cause of the sicknesses, which include kidney failure.

The supplements being investigated all used “benikoji,” a kind of red mold, including Kobayashi Pharmaceuticals’ pink pills called Benikoji Choleste Help, which were billed as helping lower cholesterol levels.

The Osaka-based Kobayashi Pharmaceutical said about a million packages were sold over the past three fiscal years. It also sold benikoji to other manufacturers, and some products have been exported. The supplements could be bought at drug stores without a prescription from a doctor.

Reports of health problems surfaced in 2023, although benikoji has been used in various products for years.

The recall came March 22, two months after the company had received official medical reports about the problem. Company president Akihiro Kobayashi has apologized for not having acted sooner.

On Friday, the company said five people had died and 114 people were being treated in hospitals after taking the products.

Japan's health ministry says the supplements could be responsible for the deaths and illnesses, and warned that the number of those affected could grow. The government has ordered a review of the approval system in response to the supplement-related illnesses.

Some analysts blame the recent deregulation initiatives, which simplified and sped up approval for health products to spur economic growth. Deaths from a mass-produced item is rare in Japan, as government checks over consumer products are relatively stringent.

This story corrects a previous version that said the supplements caused the deaths and illnesses, according to authorities. Japanese health authorities suspect the supplements are the cause, but have not yet made a determination.

AP writer Mari Yamaguchi contributed to this report.

Yuri Kageyama is on X: https://twitter.com/yurikageyama

Akihiro Kobayashi, president of Kobayashi Pharmaceutical Co., arrives at a news conference in Osaka, western Japan, Friday, March 29, 2024. In the week since a line of Japanese health supplements began being recalled, several people have died and more than 100 people were hospitalized as of Friday. The Osaka-based pharmaceutical company came under fire for not going public quickly with problems known internally as early as January. The first public announcement came March 22. (Yohei Fukuyama/Kyodo News via AP)

Akihiro Kobayashi, president of Kobayashi Pharmaceutical Co., arrives at a news conference in Osaka, western Japan, Friday, March 29, 2024. In the week since a line of Japanese health supplements began being recalled, several people have died and more than 100 people were hospitalized as of Friday. The Osaka-based pharmaceutical company came under fire for not going public quickly with problems known internally as early as January. The first public announcement came March 22. (Yohei Fukuyama/Kyodo News via AP)

An employee of Kobayashi Pharmaceutical Co. speaks to media members outside a plant operated by its subsidiary after Japan's health ministry officials walked into the plant to conduct an on-site inspection in Kinokawa, south of Osaka, western Japan, Sunday, March 31, 2024. Japanese government health officials on Sunday inspected the factory producing health supplements linked to several deaths and the hospitalization of more than 100 others, one day after the authorities investigated another plant that manufactured the product. (Yohei Fukai/Kyodo News via AP)

An employee of Kobayashi Pharmaceutical Co. speaks to media members outside a plant operated by its subsidiary after Japan's health ministry officials walked into the plant to conduct an on-site inspection in Kinokawa, south of Osaka, western Japan, Sunday, March 31, 2024. Japanese government health officials on Sunday inspected the factory producing health supplements linked to several deaths and the hospitalization of more than 100 others, one day after the authorities investigated another plant that manufactured the product. (Yohei Fukai/Kyodo News via AP)

Japan's health ministry officials walk into a plant operated by a subsidiary of Kobayashi Pharmaceutical Co. to conduct an on-site inspection in Kinokawa, south of Osaka, western Japan, Sunday, March 31, 2024. Japanese government health officials on Sunday inspected a factory producing health supplements linked to several deaths and the hospitalization of more than 100 others, one day after the authorities investigated another plant that manufactured the product. (Yohei Fukai/Kyodo News via AP)

Japan's health ministry officials walk into a plant operated by a subsidiary of Kobayashi Pharmaceutical Co. to conduct an on-site inspection in Kinokawa, south of Osaka, western Japan, Sunday, March 31, 2024. Japanese government health officials on Sunday inspected a factory producing health supplements linked to several deaths and the hospitalization of more than 100 others, one day after the authorities investigated another plant that manufactured the product. (Yohei Fukai/Kyodo News via AP)

Japan's health ministry officials walk towards a plant operated by a subsidiary of Kobayashi Pharmaceutical Co. to conduct an on-site inspection in Kinokawa, south of Osaka, western Japan, Sunday, March 31, 2024. Japanese government health officials on Sunday inspected a factory producing health supplements linked to several deaths and the hospitalization of more than 100 others, one day after the authorities investigated another plant that manufactured the product. (Yohei Fukai/Kyodo News via AP)

Japan's health ministry officials walk towards a plant operated by a subsidiary of Kobayashi Pharmaceutical Co. to conduct an on-site inspection in Kinokawa, south of Osaka, western Japan, Sunday, March 31, 2024. Japanese government health officials on Sunday inspected a factory producing health supplements linked to several deaths and the hospitalization of more than 100 others, one day after the authorities investigated another plant that manufactured the product. (Yohei Fukai/Kyodo News via AP)

A worker, left, for Kobayashi Pharmaceutical Co. stands as media members gather before Japan's health ministry officials arrive to conduct an on-site inspection at its plant in Osaka, western Japan, Saturday, March 30, 2024. Japanese government health officials raided a factory Saturday producing health supplements that they say have killed multiple people and hospitalized more than 100 others. (Yohei Fukai/Kyodo News via AP)

A worker, left, for Kobayashi Pharmaceutical Co. stands as media members gather before Japan's health ministry officials arrive to conduct an on-site inspection at its plant in Osaka, western Japan, Saturday, March 30, 2024. Japanese government health officials raided a factory Saturday producing health supplements that they say have killed multiple people and hospitalized more than 100 others. (Yohei Fukai/Kyodo News via AP)

Japan's health ministry officials walk towards the Osaka plant of Kobayashi Pharmaceutical Co. to conduct an on-site inspection in Osaka, western Japan, Saturday, March 30, 2024. Japanese government health officials raided a factory Saturday producing health supplements that they say have killed multiple people and hospitalized more than 100 others.

Japan's health ministry officials walk towards the Osaka plant of Kobayashi Pharmaceutical Co. to conduct an on-site inspection in Osaka, western Japan, Saturday, March 30, 2024. Japanese government health officials raided a factory Saturday producing health supplements that they say have killed multiple people and hospitalized more than 100 others.

Next Article

Means tosses seven shutout innings in season debut, Orioles beat Reds 2-1

2024-05-05 10:28 Last Updated At:10:30

CINCINNATI (AP) — John Means pitched seven shutout innings in his season debut and the Baltimore Orioles beat the Cincinnati Reds 2-1 on Saturday night.

Means (1-0) underwent season-ending Tommy John surgery on April 27, 2022. He returned to make four starts last September before landing back on the IL with a left forearm strain to begin this season.

“Felt pretty good,” Means said after the Orioles won for the fifth time in their last six games. “The team's playing so well, just wanted to join them and feel that energy that they're feeling. Felt like the slider and changeup was working, locating well. You want to get that first one out of the way.”

Like Cole Irvin the night before, Means kept Reds batters off balance with no walks and eight strikeouts.

“That was unbelievable,” Orioles manager Brandon Hyde said. “To go out and do that, pitch seven shutout innings, first time off of rehab, not been on a big-league mound for a while, that was way more than we anticipated.”

Means made six rehab starts for Triple-A Norfolk before being reinstated on May 1. He recorded an 8.68 ERA in those starts but said he felt fine physically.

“There's something about rehab starts with me, I don't know what it is,” Means said. “There's something about being up here that feels comfortable. Just going to ride with that. I just want to take it day by day.”

A pair of solo home runs off Reds starter Andrew Abbott (1-4) gave the Orioles a 2-0 lead.

Jorge Mateo's second homer of the season came in the fourth. Adley Rutschman, who had three hits, clubbed his fifth home run in the next inning.

The homers accounted for two of the seven hits Abbott allowed in five innings. He struck out eight with no walks.

“The results will come," Abbott said. "Stay true to yourself, stay true to what you can do. Eventually, it will turn the corner and we will be on a nice win streak and we’ll be looking back and say ‘Hey, it’s all part of the process.’ ”

The Reds who hadn't scored a run in Great American Ball Park in 26 innings, rallied in the ninth.

Pinch hitter Jake Fraley led off with a single against Craig Kimbrel to snap a career-long 0-for-22 streak. Jonathan India walked. After Kimbrel struck out Elly De La Cruz, Spencer Steer singled home a run to make the score 2-1.

Yennier Cano replaced Kimbrel and walked Tyler Stephenson to load the bases. But Cano struck out Christian Encarnacion-Strand and got Jeimer Candelario to fly out to left field for his first save of the season.

“Unbelievable job by Cano,” Hyde said. “Once we got into a groundball double play situation to end the game, Yenni is a great option for that. He walked Stephenson but got a huge punch out after and then the fly ball.”

Cincinnati avoided being shut out for the second straight night and third time in four home games.

“We had good at bats at the end,” Reds manager David Bell said. “We’ve been struggling to score runs. It's going to turn. We know that. It doesn’t make it any easier to go through. We have good players. We have to fight through it.”

UP NEXT

In Sunday's series finale, Orioles right-hander Dean Kremer (2-2, 4.19) will face Reds left-hander Nick Lodolo (3-0, 1.88) who's unbeaten since coming off the IL on April 13.

__

AP MLB: https://apnews.com/hub/mlb

Cincinnati Reds pitcher Lucas Sims throws in the eighth inning of a baseball game against the Baltimore Orioles, Saturday, May 4, 2024, in Cincinnati. (AP Photo/Carolyn Kaster)

Cincinnati Reds pitcher Lucas Sims throws in the eighth inning of a baseball game against the Baltimore Orioles, Saturday, May 4, 2024, in Cincinnati. (AP Photo/Carolyn Kaster)

Baltimore Orioles' Jorge Mateo celebrates as he scores after hitting a home run in the fourth inning of a baseball game against the Cincinnati Reds, Saturday, May 4, 2024, in Cincinnati. The Orioles won 2-1. (AP Photo/Carolyn Kaster)

Baltimore Orioles' Jorge Mateo celebrates as he scores after hitting a home run in the fourth inning of a baseball game against the Cincinnati Reds, Saturday, May 4, 2024, in Cincinnati. The Orioles won 2-1. (AP Photo/Carolyn Kaster)

Baltimore Orioles pitcher Yennier Cano (78) celebrates with catcher James McCann (27) after winning a baseball game against the Cincinnati Reds on Saturday, May 4, 2024, in Cincinnati. (AP Photo/Carolyn Kaster)

Baltimore Orioles pitcher Yennier Cano (78) celebrates with catcher James McCann (27) after winning a baseball game against the Cincinnati Reds on Saturday, May 4, 2024, in Cincinnati. (AP Photo/Carolyn Kaster)

Cincinnati Reds shortstop Elly De La Cruz (44) fields a ball hit by Baltimore Orioles' Jorge Mateo and throws to first for the out in the ninth inning of a baseball game on Saturday, May 4, 2024, in Cincinnati. (AP Photo/Carolyn Kaster)

Cincinnati Reds shortstop Elly De La Cruz (44) fields a ball hit by Baltimore Orioles' Jorge Mateo and throws to first for the out in the ninth inning of a baseball game on Saturday, May 4, 2024, in Cincinnati. (AP Photo/Carolyn Kaster)

Baltimore Orioles' Adley Rutschman, right, celebrates with third base coach Tony Mansolino, left, as he rounds the bases after hitting a home run in the fifth inning of a baseball game against the Cincinnati Reds, Saturday, May 4, 2024, in Cincinnati. (AP Photo/Carolyn Kaster)

Baltimore Orioles' Adley Rutschman, right, celebrates with third base coach Tony Mansolino, left, as he rounds the bases after hitting a home run in the fifth inning of a baseball game against the Cincinnati Reds, Saturday, May 4, 2024, in Cincinnati. (AP Photo/Carolyn Kaster)

Baltimore Orioles pitcher Yennier Cano throws in the ninth inning of a baseball game against the Cincinnati Reds, Saturday, May 4, 2024, in Cincinnati. (AP Photo/Carolyn Kaster)

Baltimore Orioles pitcher Yennier Cano throws in the ninth inning of a baseball game against the Cincinnati Reds, Saturday, May 4, 2024, in Cincinnati. (AP Photo/Carolyn Kaster)

Cincinnati Reds starting pitcher Andrew Abbott throws in the first inning of a baseball game against the Baltimore Orioles on Saturday, May 4, 2024, in Cincinnati. (AP Photo/Carolyn Kaster)

Cincinnati Reds starting pitcher Andrew Abbott throws in the first inning of a baseball game against the Baltimore Orioles on Saturday, May 4, 2024, in Cincinnati. (AP Photo/Carolyn Kaster)

Baltimore Orioles starting pitcher John Means throws in the second inning of a baseball game against the Cincinnati Reds, Saturday, May 4, 2024, in Cincinnati. (AP Photo/Carolyn Kaster)

Baltimore Orioles starting pitcher John Means throws in the second inning of a baseball game against the Cincinnati Reds, Saturday, May 4, 2024, in Cincinnati. (AP Photo/Carolyn Kaster)

Recommended Articles